These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34630097)

  • 1. Proteomic Analysis Reveals the Protective Effects of Yiqi Fumai Lyophilized Injection on Chronic Heart Failure by Improving Myocardial Energy Metabolism.
    Han X; Zhang Y; Qiao O; Ji H; Zhang X; Wang W; Li X; Wang J; Li D; Ju A; Liu C; Gao W
    Front Pharmacol; 2021; 12():719532. PubMed ID: 34630097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yiqi Fumai Injection as an Adjuvant Therapy in Treating Chronic Heart Failure: A Meta-Analysis of 33 Randomized Controlled Trials.
    Nie H; Li S; Liu M; Zhu W; Zhou X; Yan D
    Evid Based Complement Alternat Med; 2020; 2020():1876080. PubMed ID: 32922505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure.
    Zhao Y; Li Y; Tong L; Liang X; Zhang H; Li L; Fan G; Wang Y
    Front Physiol; 2018; 9():48. PubMed ID: 29467665
    [No Abstract]   [Full Text] [Related]  

  • 4. Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis.
    Gu Y; Ju A; Jiang B; Zhang J; Man S; Liu C; Gao W
    RSC Adv; 2018 Dec; 8(71):40894-40911. PubMed ID: 35557896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-QTOF/MS-based metabolomics to explore the molecular mechanisms of Yiqi Fumai Lyophilized Injection in heart failure mice.
    Yuan GY; Liu ZL; Lai Q; Fu F; Zhang L; Kou JP; Yu BY; Li F
    J Sep Sci; 2021 Jul; 44(13):2545-2563. PubMed ID: 33942520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.
    Pang LZ; Ju AC; Zheng XJ; Li F; Song YF; Zhao Y; Gu YF; Chen FL; Liu CH; Qi J; Gao Z; Kou JP; Yu BY
    J Ethnopharmacol; 2017 Apr; 202():67-77. PubMed ID: 28237302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
    Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways.
    Zhang Y; Zhang L; Zhang Y; Fan X; Yang W; Yu B; Kou J; Li F
    Front Pharmacol; 2019; 10():381. PubMed ID: 31031629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway.
    Xia Y; S D; Jiang S; Fan R; Wang Y; Wang Y; Tang J; Zhang Y; He RL; Yu B; Kou J
    Biomed Pharmacother; 2018 Dec; 108():906-913. PubMed ID: 30372902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
    Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
    Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
    Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
    J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YiQiFuMai powder injection ameliorates chronic heart failure through cross-talk between adipose tissue and cardiomyocytes via up-regulation of circulating adipokine omentin.
    Li F; Pang LZ; Zhang L; Zhang Y; Zhang YY; Yu BY; Kou JP
    Biomed Pharmacother; 2019 Nov; 119():109418. PubMed ID: 31505423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Peroxisome Proliferator-Activated Receptor γ Coactivator 1-α Protects Cardiomyocytes from Lipopolysaccharide-Induced Mitochondrial Damage and Apoptosis.
    Zhang T; Liu CF; Zhang TN; Wen R; Song WL
    Inflammation; 2020 Oct; 43(5):1806-1820. PubMed ID: 32529514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study.
    Zhang X; Kang J; Zhang J; Chen Y; Dai H; Hu M; Liu Y; Shang H
    Front Cardiovasc Med; 2022; 9():1074406. PubMed ID: 36704479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.
    Cao GS; Chen HL; Zhang YY; Li F; Liu CH; Xiang X; Qi J; Chai CZ; Kou JP; Yu BY
    J Ethnopharmacol; 2016 May; 183():18-28. PubMed ID: 26915982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
    Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
    Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKC
    Xu Y; Wang Y; Wang G; Ye X; Zhang J; Cao G; Zhao Y; Gao Z; Zhang Y; Yu B; Kou J
    Oxid Med Cell Longev; 2017; 2017():1832093. PubMed ID: 29435096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compatibility research of Yiqi Fumai injection with clinical combination based on isothermal titration calorimetry].
    Liu HY; Ma LN; Zhang P; Feng X; Xiao XH; Liu SG; Zhang YM
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):889-93. PubMed ID: 26087551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression.
    Xing L; Jiang M; Dong L; Gao J; Hou Y; Bai G; Luo G
    J Ethnopharmacol; 2013 Jun; 148(1):239-45. PubMed ID: 23619019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Qualitative and Quantitative Analysis of Multiple Chemical Constituents in YiQiFuMai Injection by Ultra-Fast Liquid Chromatography Coupled with Ion Trap Time-of-Flight Mass Spectrometry.
    Liu C; Ju A; Zhou D; Li D; Kou J; Yu B; Qi J
    Molecules; 2016 May; 21(5):. PubMed ID: 27213307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.